Risk factors

Amphastar Pharmaceuticals (AMPH) risk factors

Item 1A of every Amphastar Pharmaceuticals, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.

Open AMPH in Gloom →
Amphastar Pharmaceuticals' chart, financials and news, free in your browser.Open AMPH in Gloom →
  • FY2025 10-K risk factors
    86 risks10 new13 dropped21 reworded

    Amphastar added risks covering customer pricing leverage, macroeconomic conditions, drug delivery device single-source dependency, and ERP implementation.

    Filed Feb 26, 2026
  • FY2024 10-K risk factors
    89 risks

    Amphastar faces heavy concentration risks from top customers and critical reliance on single-source suppliers and key executives. Significant debt from the BAQSIMI acquisition and extensive regulatory oversight shape operational risks. R&D spending and ongoing product development are central to future revenue streams.

    Filed Mar 03, 2025